期刊文献+

肝细胞癌合并门静脉癌栓的治疗进展 预览 被引量:2

Recent advances on the treatment of hepatocellular carcinoma with portal vein tumor thrombus
在线阅读 下载PDF
分享 导出
摘要 门静脉癌栓是中晚期肝癌患者最常见的并发症之一,已成为影响肝癌患者术后复发转移和总体生存预后的主要因素之一。近年来,随着医疗技术的不断发展,肝癌精准治疗和多学科协作诊疗等理念不断深入,除传统的手术治疗外,局部消融术、靶向药物治疗、肝动脉栓塞化疗、三维适形放疗等多种手段的联合应用,经过临床应用证实疗效更加显著,肝癌合并门静脉癌栓的综合治疗理念已贯穿始终。本文就肝细胞癌伴门静脉癌栓的最新治疗进展做一综述,以供临床参考。 Portal vein tumor thrombus is one of the most common complications of advanced liver cancer.It has become one of the main factors that affect the recurrence and metastasis and the overall survival prognosis of hepatocellular carcinoma patients.In recent years,with the continuous development of medical technology,accurate treatment of liver cancer and multidisciplinary collaboration treatment and other concepts continue to deepen.In addition to traditional surgical treatment,a variety of means of joint application with local ablation,targeted drug therapy,hepatic artery embolization chemotherapy,three-dimensional conformal radiotherapy,have been confirmed more significant after clinical application,and the concept of comprehensive treatment for the patients of liver cancer with portal vein tumor thrombus has been through.This article summarizes the latest advances in hepatocellular carcinoma with portal vein tumor thrombus for clinical reference.
作者 代柏树 杨振宇 杜锡林 陈安 鲁建国 Dai Baishu, Yang Zhenyu, Du Xilin, Chen An, Lu Jianguo( Department of General Surgery, Tangdu Hospital of The Fourth Military Medical University, Shaanxi Xi'an 710038, China.)
出处 《现代肿瘤医学》 CAS 2018年第10期1619-1623,共5页 Journal of Modern Oncology
基金 陕西省科技统筹创新工程计划项目(编号:2015KTCL03-05)
关键词 原发性肝癌 门静脉癌栓 索拉非尼 局部消融 hepatocellular carcinoma, portal vein tumor throlnbus, sorafenib,local ablation therapy
作者简介 代柏树(1988-),男,河北廊坊人,在读硕士研究生,主要从事肝癌临床研究工作.E-mail:daibaishu1988@163.com;【通讯作者】杜锡林(1966-),男,四川南部人,主任医师,博士,教授,硕士生导师,主要从事肝脏肿瘤的微创治疗及基础研究工作.E-mail:dxlin0705@163.com
  • 相关文献

参考文献9

二级参考文献192

共引文献92

同被引文献31

引证文献2

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈